Comparison of antitumor effects of daunorubicin covalently linked to poly-l-amino acid carriers
- 1 March 1984
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 20 (3), 421-425
- https://doi.org/10.1016/0277-5379(84)90091-9
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Anti‐tumor activity of daunorubicin linked to poly‐L‐aspartic acidInternational Journal of Cancer, 1982
- Reduction of Doxorubicin Cardiotoxicity by Prolonged Continuous Intravenous InfusionAnnals of Internal Medicine, 1982
- Cis-aconityl spacer between daunomycin and macromolecular carriers: A model of pH-sensitive linkage releasing drug from a lysosomotropic conjugateBiochemical and Biophysical Research Communications, 1981
- TARGETING OF DRUGS: IMPLICATIONS IN MEDICINEThe Lancet, 1981
- Trypanocidal activity of daunorubicin and related compoundsNature, 1981
- Conjugation of methotrexate to poly (L-lysine) as a potential way to overcome drug resistanceCancer, 1980
- Antibodies as specific carriers for chemotherapeutic agentsCancer Chemotherapy and Pharmacology, 1979
- EndocytosisAnnual Review of Biochemistry, 1977
- The Functions of the Macrophage in Malignant DiseaseAnnual Review of Medicine, 1976
- Suppression of tumour growth in mice by a drug–antibody conjugate using a novel approach to linkageNature, 1975